قالب وردپرس درنا توس
Home / Tag Archives: AveXis

Tag Archives: AveXis

NC officials, biotech company AveXis, announce expansion

RESEARCH TRIANGLE PARK – State and local authorities announced on Monday a plan by a biotech company calling for new jobs and expansion of the company's presence at Research Triangle Park. North Carolina Commerce Secretary Anthony Copeland partnered with local dignitaries and other officials from the North Carolina Biotechnology Center to announce the expansion plan by gene manufacturing company AveXis. …

Read More »

Novartis Wager on AveXis shows mega-prizes for rare diseases

Novartis AG's $ 8.7 billion acquisition of AveXis Inc. is Big Pharma's latest bet that rare disease treatments are worth the money. Novartis receives an experimental drug for a rare, often deadly disease in children's time as competition recovers to get therapies for rare diseases: Takeda Pharmaceutical Co. pursues Shire Plc in an agreement Sanofi agreed in January to get …

Read More »

Novartis inks $ 8.7B AveXis buyout to build gene therapy unit

Novartis has signed a $ 8.7 billion purchase agreement to buy AveXis. With this step, the new CEO of Novartis, Dr. Vas Narasimhan, a high premium to establish the company as a pioneer in the emerging gene therapy sector. With the completion of the cashless agreement, Novartis gains control of Phase 3 gene therapy for the treatment of the rare …

Read More »

Novartis Selects Gene Therapy with an AveXis $ 8.7 Billion Deal

ZURICH (Reuters) – Novartis ( NOVN.S ) continues with AveXis ( AVXS.O ) into gene therapy with sales of $ 8.7 billion Treating rare diseases that reap billions and strengthen their technology base. Logo of the Swiss pharmaceutical manufacturer Novartis at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018. REUTERS / Arnd Wiegmann The acquisition is the latest …

Read More »

Novartis to Buy AveXis in $ 8.7 Billion Gene Therapy Deal

By EDT Updated on April 19, 2018, 2:31 AM EDT Novartis AG agreed to acquire AveXis Inc. for Shareholders of the Bannockburn, Illinois-based company seeks to receive a $ 218 share in cash in a tender offer, Novartis said in a [19659008] statement Monday. AveXis is closed Friday. AveXis is developing a product, AVXS-101, to treat spinal muscular atrophy, an …

Read More »

Novartis buys gene therapy company AveXis for $ 8.7 billion

. 9 April 2018 1:25 pm ET Novartis AG NVS -1.06% said Monday that it agreed to buy a US-based clinical-stage gene therapy company AveXis Inc. AVX's -3.09% for $ 8.7 billion. The pharmaceutical company will pay $ 218 on April 6 for an AveXis share, a premium of 88% over its closing price. It intends to finance the acquisition …

Read More »